Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX AMZN BIIB TSLA WYNN ILMN SLXP ALXN AMGN GMCR Z COST SSYS FFIV PCYC SBAC GILD VRTX
Nyse: ACT V LNKD IVV PXD IBM GS LMT AGN SPG FDX WHR TWC PRGO MMM CMI HUM APD XEC CXO
New Highs: BLK ACT IVV GS LMT SLXP MMM AMGN GMCR HUM NOC UTHR GD MTB FFIV WLP ECL NSC JNJ EXP

The Hot Industries

Aerospace/Defense Products & Services 2
Health Care Plans 2
Drugs - Generic 2

The Hot Sectors

Healthcare 7
Industrial Goods 5
Financial 3

ARIA Stock Chart


ARIA
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

307
Monthly

Website:

http://www.ariad.com

ARIA Ariad Pharmaceuticals Inc.

ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors. Iclusig is a tyrosine kinase inhibitor (TKI) that is approved in the United States for the treatment of adult patients with chronic, accelerated, or blast phase chronic myeloid leukemia, who are resistant or intolerant to prior TKI therapy, as well as for the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, who are resistant or intolerant to prior TKI therapy. Its product pipeline consists of AP26113, an investigational dual inhibitor of anaplastic lymphoma kinase, which is being studied in a phase I/II clinical trial in patients with advanced solid tumors comprising non-small cell lung cancer; Ridaforolimus, an investigational mTOR inhibitor, which is being studied in multiple clinical trials in patients with various types of cancers; and AP1903, a small-molecule dimerizer drug. The company sells and markets Iclusig through specialty pharmacies and specialty distributors in the United States. It has collaboration and license agreement with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus, for use in cancer; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.

favicon

Why Ariad Pharmaceuticals, Inc. Stock Plunged 11% in 2014

8 Sep 2014, 1:07 pmWhy Ariad Pharmaceuticals, Inc. Stock Plunged 11% in 2014
favicon

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte

5 Sep 2014, 2:20 pmBiotech columnist Adam Feuerstein answers readers' questions about health care. Click to view a price quote on ACHN . Click to research the Drugs industry.
favicon

'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around

4 Sep 2014, 4:28 ama Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks callers offered up during the Mad Money Lightning Round Wednesday evening: Yahoo! : "This is one of the best buys in this market." Ariad Pharmaceuticals : "That is a good one." Targa Resources Partners : "This ...
favicon

Lightning Round: Yahoo!, Taser & more

3 Sep 2014, 5:06 pmCramer makes the call on viewer favorites.
favicon

These 3 Stocks Have Huge Insider Buying

30 Aug 2014, 2:36 amAs earnings season comes to an end, so does the opportunity for a company’s officers and directors to snap up company shares with their own money. Most corporate governance policies restrict such
favicon

Why Ariad Pharmaceuticals (ARIA) Stock Is Up Today

26 Aug 2014, 10:43 amNEW YORK (TheStreet) --aAriad Pharmaceuticalsa rose Tuesday as Roche's $8.3 billion acquisition ofaInterMunea has led the biotech sector higher. Roche will pay $74 a share for InterMune, which represents a 38% premium to Friday's closing price of $53.80, in an all-cash deal. Ariadawas up 6.43% to $6.62 at 12:35 p.m. More than 8.3 million shares had changed hands to edge the average volume ofa8 ...
favicon

After Hours Most Active for Aug 25, 2014 : KMI, T, QQQ, CCG, APC, FDO, BAC, MSFT, AAPL, SIRI, CSCO, ARIA

25 Aug 2014, 3:59 pmAfter Hours Most Active for Aug 25, 2014 : KMI, T, QQQ, CCG, APC, FDO, BAC, MSFT, AAPL, SIRI, CSCO, ARIA
favicon

Biotechs Rise After InterMune Acquired by Roche

25 Aug 2014, 11:58 amNEW YORK (TheStreet) -- Shares of a number of biopharmaceutical companies are climbing after drug maker Roche agreed to buy its smaller peer, Intermunea . InterMune focuses on developing treatments for respiratory and orphan fibrotic diseases. Watch the video below to get Jim Cramer's take on Roche's acquisition of InterMune: WATCH: More market update videos on TheStreet TV | More videos from ...
favicon

GNC, Southern Copper And Others Insiders Have Been Buying

25 Aug 2014, 11:34 amAnnaly Capital Management, GNC Holdings and Southern Copper are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says ...
favicon

With a little help from my friends

23 Aug 2014, 6:38 amTata Motors looks to shed its old skin, with more than a little help from Jaguar Land Rover.